This article is more than 5 years old. Information may no longer be current.
Mount Sinai Health System appoints bladder cancer program director
Peter Wiklund, MD, PhD, has been appointed director of the bladder cancer program at Mount Sinai Health System.
Wiklund also will serve as professor of urology in the department of urology at Icahn School of Medicine at Mount Sinai.
“It is an honor to join Mount Sinai’s department of urology, which is recognized for its robotic and reconstructive surgical teams in bladder, kidney, and prostate cancers,” Wiklund said in a press release.
Wiklund — recognized as a pioneer of robot-assisted cystectomy — previously served as chair of urology, molecular medicine and surgery, as well as professor of urology, at Karolinska Institutet in Stockholm.
He has performed more than 3,000 robotic operations, and he also has extensive experience in advanced oncological surgery for patients whose tumors are growing on several pelvic organs.
Wiklund is chair of the scientific working group of the European Urology Robotic Section of the European Association of Urology.
"We’re excited to have Dr. Wiklund join our team of physicians,” Ash Tewari, MBBS, MCh, chair of the department of urology at Mount Sinai Health System, said in the release. “Dr. Wiklund’s renowned techniques, including his ability to robotically reconstruct the ileum inside the body, lead to great benefits for his patients.”